 |
everolimus |
|---|---|
| Trade Name | Afinitor |
| Orphan Indication | Neuroendocrine tumors |
| USA Market Approval | USA |
| USA Designation Date | 2008-02-14 00:00:00 |
| Sponsor | Novartis Pharmaceuticals Corporation;One Health Plaza, Build 337, A14.5D;East Hanover, New Jersey, 07936 |
| |
everolimus |
|---|---|
| Trade Name | Afinitor |
| Orphan Indication | Neuroendocrine tumors |
| USA Market Approval | USA |
| USA Designation Date | 2008-02-14 00:00:00 |
| Sponsor | Novartis Pharmaceuticals Corporation;One Health Plaza, Build 337, A14.5D;East Hanover, New Jersey, 07936 |